Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has granted equity awards to six recently hired employees as inducements to join the company. The grants, consisting of restricted stock units (RSUs), …
Neuronetics Issues Inducement Equity Awards to New Hires Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) delivered a solid second quarter, posting $38.1 million in total revenue—an 18% increase on an adjusted pro forma basis—as the company continues to benefit …
Neuronetics Posts Strong Q2 Revenue Growth, Secures $10M in New Funding as Greenbrook Integration Advances Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced new real-world data demonstrating that its NeuroStar transcranial magnetic stimulation (TMS) therapy delivers meaningful improvement in depression symptoms among adolescents and young adults. …
Neuronetics Study Shows Strong Antidepressant Results for Teens and Young Adults Using NeuroStar TMS Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced its plans to release financial and operating results for the second quarter of 2025 on Tuesday, August 5, 2025, prior to the …
Neuronetics to Announce Q2 2025 Results on August 5th Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that Steven Pfanstiel will join the company as Chief Financial Officer, effective July 15, 2025. He succeeds Steve Furlong, who will retire …
Neuronetics Appoints New CFO as Company Targets Growth and Profitability Milestones Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced its upcoming inclusion in the Russell 3000® Index and the Russell 2000® Index following the annual reconstitution of the Russell indexes. This …
Neuronetics to Join Russell 3000 and Russell 2000 Indexes, Boosting Institutional Visibility Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) reported an impressive 84% revenue increase to $32.0 million for the first quarter of 2025, attributed primarily to the acquisition of Greenbrook TMS. …
Neuronetics Posts Strong Revenue Growth in Q1 2025 Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced this week the granting of inducement awards of Restricted Stock Units (RSUs) totaling 4,500 shares of the Company’s common stock to three …
Neuronetics Announces Inducement Awards for New Team Members Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced it will release its first quarter 2025 financial and operating results before market open on Tuesday, May 6, 2025.
Neuronetics to Announce Q1 2025 Results and Host Live Conference Call on May 6 Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) revealed a significant development in mental healthcare, announcing that Evernorth Health Services, a subsidiary of The Cigna Group, has expanded its coverage of NeuroStar® …
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression Read More